Health in Venezuela

Last updated

Estimated malaria case in Venezuela Malaria in Venezuela.png
Estimated malaria case in Venezuela
Life expectancy in Venezuela Life expectancy in Venezuela.svg
Life expectancy in Venezuela

The recent state of health in Venezuela has seen that from 1992 to 1993, there was a cholera epidemic in the Orinoco Delta and Venezuela's political leaders were accused of racial profiling of their own indigenous people to deflect blame from the country's institutions, thereby aggravating the epidemic. [1] During the 1990s, the mortality rate was 318 per 100,000 people for heart and heart-related diseases, 156 for cancers, 634 for external causes (including drowning, self-harm, violence, falls, road accidents etc.), 1,126 for communicable diseases such as chest infections, syphilis, and meningitis, and 654 for certain congenital conditions. [2]

Contents

Several transmissible diseases, including dengue fever, malaria, measles, and tuberculosis, reappeared in Venezuela. In 1999 an estimated 62,000 Venezuelans were living with acquired immune deficiency syndrome (AIDS), and in 2001 an estimated 2,000 people died from AIDS. At the end of 2003, the percentage of the population between the ages of 15 and 49 with human immunodeficiency virus (HIV)/AIDS was 0.7. In 2000, 85% of the urban population and 70% of the rural population had access to potable water. Sanitation levels improved for 71% of the urban population and 48% of the rural population. In August 2001, President Hugo Chávez announced a national campaign to fight the dengue fever epidemic that had infected 24,000 and killed four. Child immunization for measles in 2002 (as a percentage of those under 12 months of age) dropped to 78%, compared with 84% in 1999.[ citation needed ]

In August 2014, Venezuela was the only country in Latin America where the incidence of malaria was increasing, allegedly due to illegal mining; and in 2013, Venezuela registered the highest number of cases of malaria in the past 50 years, with 300 out of every 100,000 Venezuelans being infected with the disease. Medical shortages in the country also hampered the treatment of Venezuelans. [3] Shortages of antiretroviral medicines to treat HIV/AIDS affected about 50,000 Venezuelans, potentially causing thousands of Venezuelans with HIV to develop AIDS. [4] Venezuelans also stated that due to shortages of medicines, it was hard to find acetaminophen to help alleviate the newly introduced chikungunya virus, a potentially lethal mosquito-borne disease. [5] In September 2014, Health Minister Nancy Pérez admitted that there were 45,745 cases of dengue fever. [6] There were also contested estimates involving the number of Venezuelans infected with chikungunya. In September 2014, the Venezuelan government stated that only 400 Venezuelans were infected with chikungunya [6] while the Central University of Venezuela stated that there could be between 65,000 and 117,000 Venezuelans infected. [7] In August 2015, independent health monitors said that there were more than two million people infected with chikungunya while the government said there were 36,000 cases. [8]

In October 2014, President Maduro announced a plan to create the University of Science and Health and called for a meeting of ALBA to discuss measures against the Ebola virus disease during the Ebola virus epidemic in West Africa. [9]

In 2016, according to the Venezuelan government, 240,000 cases of malaria were reported, rising 76% in one year. [10] Former Venezuelan health minister José Félix Oletta estimated that more than 500,000 Venezuelans would contract malaria in 2017. [10] 324 suspected diphtheria cases were reported in 2016, the first since 1992, and increasing numbers in following years, with 287 deaths up to the end of 2018. There are reports of diphtheria spreading to other South American countries from Venezuela. [11]

In April 2017 Venezuela's health ministry reported that maternal mortality had jumped by 65% in 2016 and that the number of infant deaths rose by 30%. [12] It also said that the number of cases of malaria was up by 76%. [13] The ministry had not reported health data in two years, and none has been reported since. [10] In May, Maduro sacked the health minister, Antonieta Caporale, for publishing the damning statistics. [10]

In November 2017 the Venezuelan Society of Public Health reported that a total of 857 cases of measles, of which 465 had been confirmed, had been registered. The Pan American Health Organization reported that at least 71% of the reported cases of measles in 2017 occurred in Venezuela. [14]

See also

Related Research Articles

<span class="mw-page-title-main">Dengue fever</span> Tropical disease caused by the dengue virus, transmitted by mosquito

Dengue fever is a mosquito-borne tropical disease caused by the dengue virus. Symptoms typically begin three to fourteen days after infection. These may include a high fever, headache, vomiting, muscle and joint pains, and a characteristic skin itching and skin rash. Recovery generally takes two to seven days. In a small proportion of cases, the disease develops into a more severe dengue hemorrhagic fever, resulting in bleeding, low levels of blood platelets and blood plasma leakage, or into dengue shock syndrome, where dangerously low blood pressure occurs.

<span class="mw-page-title-main">Health care in Venezuela</span>

After the Bolivarian Revolution, extensive inoculation programs and the availability of low- or no-cost health care provided by the Venezuelan Institute of Social Security made Venezuela's health care infrastructure one of the more advanced in Latin America.

<span class="mw-page-title-main">Epidemiology of chikungunya</span>

Chikungunya is a mosquito-borne alpha virus that was first isolated after a 1952 outbreak in modern-day Tanzania. The virus has circulated in forested regions of sub-Saharan African in cycles involving nonhuman primate hosts and arboreal mosquito vectors. Phylogenetic studies indicate that the urban transmission cycle—the transmission of a pathogen between humans and mosquitoes that exist in urban environments—was established on multiple occasions from strains occurring on the eastern half of Africa in non-human primate hosts. This emergence and spread beyond Africa may have started as early as the 18th century. Currently, available data does not indicate whether the introduction of chikungunya into Asia occurred in the 19th century or more recently, but this epidemic Asian strain causes outbreaks in India and continues to circulate in Southeast Asia.

Globalization, the flow of information, goods, capital, and people across political and geographic boundaries, allows infectious diseases to rapidly spread around the world, while also allowing the alleviation of factors such as hunger and poverty, which are key determinants of global health. The spread of diseases across wide geographic scales has increased through history. Early diseases that spread from Asia to Europe were bubonic plague, influenza of various types, and similar infectious diseases.

A reverse zoonosis, also known as a zooanthroponosis or anthroponosis, is a pathogen reservoired in humans that is capable of being transmitted to non-human animals.

Aircraft disinsection is the use of insecticide on international flights and in other closed spaces for insect and disease control. Confusion with disinfection, the elimination of microbes on surfaces, is not uncommon. Insect vectors of disease, mostly mosquitoes, have been introduced into and become indigenous in geographic areas where they were not previously present. Dengue, chikungunya and Zika spread across the Pacific and into the Americas by means of the airline networks. Cases of "airport malaria", in which live malaria-carrying mosquitoes disembark and infect people near the airport, may increase with global warming.

<span class="mw-page-title-main">Health in Pakistan</span> Overview of health in Pakistan

Pakistan is the fifth most populous country in the world with population approaching 225 million. It is a developing country struggling in many domains due to which the health system has suffered a lot. As a result of that, Pakistan is ranked 122nd out of 190 countries in the World Health Organization performance report.

<span class="mw-page-title-main">Health in Thailand</span> Overview of health in Thailand

Thailand has had "a long and successful history of health development," according to the World Health Organization. Life expectancy is averaged at seventy years. Non-communicable diseases form the major burden of morbidity and mortality, while infectious diseases including malaria and tuberculosis, as well as traffic accidents, are also important public health issues.

HIV/AIDS in Bolivia has a less than 1 percent prevalence of Bolivia's adult population estimated to be HIV-positive. Bolivia has one of the lowest HIV prevalence rates in the Latin America and Caribbean region.

<span class="mw-page-title-main">Mosquito-borne disease</span> Diseases caused by bacteria, viruses or parasites transmitted by mosquitoes

Mosquito-borne diseases or mosquito-borne illnesses are diseases caused by bacteria, viruses or parasites transmitted by mosquitoes. Nearly 700 million people get a mosquito-borne illness each year resulting in over 725,000 deaths.

<span class="mw-page-title-main">Health in Cambodia</span>

The quality of health in Cambodia is rising along with its growing economy. The public health care system has a high priority from the Cambodian government and with international help and assistance, Cambodia has seen some major and continuous improvements in the health profile of its population since the 1980s, with a steadily rising life expectancy.

<span class="mw-page-title-main">Health in Bangladesh</span>

Bangladesh is one of the most populous countries in the world, as well as having one of the fastest growing economies in the world. Consequently, Bangladesh faces challenges and opportunities in regards to public health. A remarkable metamorphosis has unfolded in Bangladesh, encompassing the demographic, health, and nutritional dimensions of its populace.

<span class="mw-page-title-main">Dengue fever outbreaks</span> Disease outbreak

As of 2010, dengue fever is believed to infect 50 to 100 million people worldwide a year with 1/2 million life-threatening infections. It dramatically increased in frequency between 1960 and 2010, by 30 fold. This increase is believed to be due to a combination of urbanization, population growth, increased international travel, and global warming. The geographical distribution is around the equator with 70% of the total 2.5 billion people living in endemic areas from Asia and the Pacific. Many of the infected people during outbreaks are not virally tested, therefore their infections may also be due to chikungunya, a coinfection of both, or even other similar viruses.

Even though Panama has one of the fastest growing economies in the western hemisphere, an estimated 500,000 people are in extreme poverty. Panama has major socioeconomic and health inequalities between the country’s urban and rural populations. The indigenous population lives in more disadvantaged conditions and experiences greater vulnerability in health. In general, the population living in more marginalized areas has less service coverage and less access to health care.

The United States Intelligence Community (IC) has a long history of producing assessments on infectious diseases. Most of these papers are distributed to government administrators and inform the choices of policymakers. Three of these assessments stand out as analytical products that have had important impact on the awareness, funding and treatment of infectious diseases around the world. The first paper is the National Intelligence Estimate on the Global Infectious Disease Threat, the second paper is the assessment on the Next Wave of HIV/AIDS, and the third paper was the assessment on SARS. This page summarizes the findings of these three papers and provides information about their impact.

The 2013–2014 chikungunya outbreak represented the first recorded outbreak of the disease outside of tropical Africa and Asia. In December 2013, the first locally transmitted case of chikungunya in the Americas was detected in Saint Martin. Shortly after the first case the disease began to spread rapidly throughout the Caribbean region. By the end of the year, it had spread to Martinique and Guadeloupe, with suspected cases in Saint Barthélemy. By the end of January 2014, cases had been confirmed in Saint Barthélemy, as well as the British Virgin Islands, Dominica, and French Guiana. On the basis of 4,000 confirmed cases and over 30,000 suspected cases, the Caribbean Public Health Agency (CARPHA) declared a Caribbean-wide epidemic of the virus in early May. By the end of May, four cases of chikungunya had been confirmed in Florida. By July 2014 there were an estimated 355,000 cases in the Caribbean. By August 2014, 25 Caribbean countries had confirmed at least one case. The epidemic was over by 2015.

<span class="mw-page-title-main">Ebola virus disease in Mali</span>

Ebola virus disease in Mali occurred in October 2014, leading to concern about the possibility of an outbreak of Ebola in Mali. A child was brought from Guinea and died in the northwestern city of Kayes. Mali contact traced over 100 people who had contact with the child; tracing was completed in mid-November with no further cases discovered. In November, a second unrelated outbreak occurred in Mali's capital city, Bamako. Several people at a clinic are thought to have been infected by a man traveling from Guinea. On January 18, Mali was declared Ebola-free after 42 days with no new cases. There had been a cumulative total of eight cases with six deaths.

The Norwegian Institute of Public Health is responsible for maintaining and revising the list of notifiable diseases in Norway and participates in the European Centre for Disease Prevention and Control (ECDC) and the World Health Organization's surveillance of infectious diseases. The notifiable diseases are classified into Group A, Group B and Group C diseases, depending on the procedure for reporting the disease.

A notifiable disease is one which the law requires to be reported to government authorities.

References

  1. Briggs, Charles L. Stories in the time of cholera: Racial profiling during a medical nightmare. Univ of California Press, 2003 pp.3-5
  2. GBD Profile Venezuela http://www.healthdata.org/sites/default/files/files/country_profiles/GBD/ihme_gbd_country_report_venezuela.pdf
  3. Pardo, Daniel (23 August 2014). "The malaria mines of Venezuela". BBC. Retrieved 31 August 2014.
  4. "Venezuela Faces Health Crisis Amid Shortage of HIV/Aids Medication". Fox News Latino. 14 May 2014. Retrieved 31 August 2014.
  5. Forero, Juan (22 September 2014). "Venezuela Seeks to Quell Fears of Disease Outbreak". The Wall Street Journal. Retrieved 24 September 2014.
  6. 1 2 "Venezuela's Maduro denounces "psychological war" waged by opposition". El Pais. 19 September 2014. Retrieved 24 September 2014.
  7. Wade, Lizzie (23 September 2014). "In Venezuela, doctor flees after being accused of terrorism amid fever outbreak". Science. Retrieved 28 September 2014.
  8. "Thousands dying early as medical system implodes in Venezuela". The Times. 5 August 2015. Retrieved 2 May 2019.
  9. "Maduro crea Universidad de las Ciencias y de la Salud". El Universal. 8 October 2014. Retrieved 9 October 2014.
  10. 1 2 3 4 J.R.A. (12 October 2017). "Why malaria is spreading in Venezuela". The Economist .
  11. Paniz-Mondolfi, Alberto E.; Tami, Adriana; Grillet, Maria E.; Márquez, Marilianna; Hernández-Villena, Juan; Escalona-Rodríguez, María A.; Blohm, Gabriela M.; Mejías, Isis; Urbina-Medina, Huníades; Rísquez, Alejandro; Castro, Julio; Carvajal, Ana; Walter, Carlos; López, María G.; Schwabl, Philipp; Hernández-Castro, Luis; Miles, Michael A.; Hotez, Peter J.; Lednicky, John; Morris, J. Glenn; Crainey, James; Luz, Sergio; Ramírez, Juan D.; Sordillo, Emilia; Llewellyn, Martin; Canache, Merari; Araque, María; Oletta, José (April 2019). "Resurgence of Vaccine-Preventable Diseases in Venezuela as a Regional Public Health Threat in the Americas". Emerging Infectious Diseases. CDC. 25 (4): 625–632. doi:10.3201/eid2504.181305. PMC   6433037 . PMID   30698523.
  12. "Politics this week". The Economist.
  13. . https://www.economist.com/news/world-week/21721971-politics-week
  14. Nacional, El (4 December 2017). "Venezuela acumula 465 casos confirmados de sarampión". El Nacional.